Sort   by:  
 Page size 
UnknownBlinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis.
Not available
S-EPMC8945309 | biostudies-literature
UnknownA multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.
Not available
S-EPMC5595986 | biostudies-literature
UnknownHigh-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis.
Not available
S-EPMC6723410 | biostudies-literature
UnknownConditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.
Not available
S-EPMC5410259 | biostudies-literature
UnknownAnti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.
Not available
S-EPMC10256422 | biostudies-literature
UnknownLow platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.
Not available
S-EPMC3291595 | biostudies-literature
UnknownAssociation between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study.
Not available
S-EPMC10521383 | biostudies-literature
UnknownSymptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort.
Not available
S-EPMC9383387 | biostudies-literature
UnknownBurden of post-acute COVID-19 sequelae in healthcare workers and its course over a 30-month period-results from a prospective multicentre cohort.
Not available
S-EPMC12316709 | biostudies-literature
UnknownThe brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.
Not available
S-EPMC5917603 | biostudies-literature
Sort   by:  
 Page size